Category: Defective Drugs
Millions of Americans take vitamin and dietary supplements every day, but few consider them harmful. However, they are not without risk.
Close to one out of four general aviation pilots who died in plane accidents between 2008 and 2012 tested positive for at least one drug which potentially could impair performance in the cockpit. This was the result of the NTSB (National Transportation Safety Board) study which was released earlier this month, September 2014.
Do the benefits of taking the prescription outweigh the risks for the population the drug is intended to treat and for its intended use? This is the question that the U. S. Food and Drug Administration (FDA) asks when it is determining whether a drug is "safe"; whether it should be approved, or whether it should be recalled.
Many individuals who are facing serious illnesses or lifelong afflictions rely on pharmaceutical drugs to help them deal with whatever is medically ailing them. Most of the people who take pharmaceutical drugs also expect those drugs to do for them what their doctors say they should do. Nonetheless, there are certain drugs on the market that fail to work as the doctor expects them to work. Such drugs are defective, and the unsuspecting individual who takes a defective drug often suffers because...
It has been more than a year since the nationwide outbreak of fungal meningitis caused by the New England Compounding Center in Massachusetts. Since the outbreak began in September 2012, more than 700 out of 14,000 people receiving tainted injections have fallen ill, including 24 this year.
"Prescription drugs can save lives and cure medical conditions. They may also do harm. It is important for patients and doctors to be aware of drug recalls."
Recall - Ameridose, sister company of New England Compounding Center (NECC) issues recalls on all of its productsNovember 6, 2012 | Category: Defective Drugs
According to an Food & Drug Administration (FDA) press release October 31, 2012, Ameridose, Westborough, MA, sister company of the New England Compounding Center, Framingham, MA linked to more than 30 deaths caused by contaminated products, informed its customers of its voluntary recall of all of its products following the FDA's inspection which found "shortcomings in testing procedures". The FDA has called for improvement in Ameridose's sterility testing process.